BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18827162)

  • 1. Dental units as infection sources of Pseudomonas aeruginosa.
    Barben J; Schmid J
    Eur Respir J; 2008 Oct; 32(4):1122-3. PubMed ID: 18827162
    [No Abstract]   [Full Text] [Related]  

  • 2. Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients.
    Hall AJ; Fothergill JL; McNamara PS; Southern KW; Winstanley C
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):324-6. PubMed ID: 25284374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there value in susceptibility testing of Pseudomonas aeruginosa causing chronic infection in patients with cystic fibrosis?
    Gilligan PH
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):711-5. PubMed ID: 17140346
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis.
    Agarwal G; Kapil A; Kabra SK; Das BK
    Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494
    [No Abstract]   [Full Text] [Related]  

  • 5. Contribution of tap water and environmental surfaces to nosocomial transmission of antibiotic-resistant Pseudomonas aeruginosa.
    Muscarella LF
    Infect Control Hosp Epidemiol; 2004 Apr; 25(4):342-5. PubMed ID: 15108733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dental units as sources of contamination by Pseudomonas aeruginosa].
    Exner M; Haun F; Kocikowski R
    Dtsch Zahnarztl Z; 1981; 36(12):819-24. PubMed ID: 6797810
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic.
    Williams T
    Br J Biomed Sci; 1997 Sep; 54(3):181-5. PubMed ID: 9499595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.
    Armstrong D; Bell S; Robinson M; Bye P; Rose B; Harbour C; Lee C; Service H; Nissen M; Syrmis M; Wainwright C
    J Clin Microbiol; 2003 May; 41(5):2266-7. PubMed ID: 12734299
    [No Abstract]   [Full Text] [Related]  

  • 9. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
    Tümmler B; Koopmann U; Grothues D; Weissbrodt H; Steinkamp G; von der Hardt H
    J Clin Microbiol; 1991 Jun; 29(6):1265-7. PubMed ID: 1907611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract]   [Full Text] [Related]  

  • 11. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.
    Geddes DM
    Lancet; 2001 Aug; 358(9281):522-3. PubMed ID: 11520516
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudomonas aeruginosa respiratory tract infections associated with contaminated ultrasound gel used for transesophageal echocardiography—Michigan, December 2011–January 2012.
    Clin Infect Dis; 2012 Jul; 55(2):ii. PubMed ID: 22912968
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients.
    Schelstraete P; Van Daele S; De Boeck K; Proesmans M; Lebecque P; Leclercq-Foucart J; Malfroot A; Vaneechoutte M; De Baets F
    Eur Respir J; 2008 Apr; 31(4):822-9. PubMed ID: 18094014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis unit.
    Denton M; Littlewood JM; Brownlee KG; Conway SP; Todd NJ
    Lancet; 1996 Dec; 348(9041):1596-7. PubMed ID: 8950918
    [No Abstract]   [Full Text] [Related]  

  • 16. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
    J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased virulence of cystic fibrosis Pseudomonas aeruginosa in Dictyostelium discoideum.
    Bradbury RS; Reid DW; Inglis TJ; Champion AC
    Microbiol Immunol; 2011 Apr; 55(4):224-30. PubMed ID: 21272061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas cepacia in cystic fibrosis patients.
    Prince A
    Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monitoring of antibiotic resistance in Ps. aeruginosa and in Ps. maltophilia in the Ospedale di Pordenone].
    Chiaradia V; Santini GF
    G Ital Chemioter; 1988; 35(1-3):23-5. PubMed ID: 3151487
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Güzel C; Gerçeker AA
    J Antibiot (Tokyo); 2012 Feb; 65(2):83-6. PubMed ID: 22126897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.